福安药业集团湖北人民制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
44
NMPA:44
Drug Approvals
Midazolam Hydrochloride Oral Solution
- Product Name
- 盐酸咪达唑仑口服溶液
- Approval Number
- 国药准字H20253287
- Approval Date
- Jan 24, 2025
NMPA
Midazolam Hydrochloride Oral Solution
- Product Name
- 盐酸咪达唑仑口服溶液
- Approval Number
- 国药准字H20253288
- Approval Date
- Jan 24, 2025
NMPA
Sodium Valproate Oral Solution
- Product Name
- 丙戊酸钠口服溶液
- Approval Number
- 国药准字H20243506
- Approval Date
- Apr 17, 2024
NMPA
Levocetirizine Dihydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20234579
- Approval Date
- Dec 5, 2023
NMPA
Methylprednisolone Sodium Succinate for Injection
- Product Name
- 注射用甲泼尼龙琥珀酸钠
- Approval Number
- 国药准字H20237074
- Approval Date
- Jul 5, 2023
NMPA
Tigecycline for Injection
- Product Name
- 注射用替加环素
- Approval Number
- 国药准字H20183146
- Approval Date
- Mar 21, 2023
NMPA
Esomeprazole Sodium for Injection
- Product Name
- 注射用艾司奥美拉唑钠
- Approval Number
- 国药准字H20183130
- Approval Date
- Mar 21, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found